Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Burzynski Research Institute Inc

+ Add to Watchlist


0.1100 USD 0.00000.00%

As of 20:10:00 ET on 02/19/2015.

Company Profile for Burzynski Research Institute Inc (BZYR)

Burzynski Research Institute, Inc. manufactures medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids. The Company is conducting clinical trials of Antineoplastons relating to the treatment of cancer. Burzynski is seeking Food and Drug Administration approval for the sale of Antineoplastons.

Contact Information

Burzynski Research Institute Inc

9432 Katy Freeway
Houston, TX 77055
United States
Phone: 1-713-335-5697
Fax: 1-713-935-0649

Key Executives for Burzynski Research Institute Inc (BZYR)

Stanislaw R BurzynskiChairman/PresidentTomasz JanickiVP:Clinical Trials
Patryk P GoscianskiTreasurer/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil